Beovu

Brolucizumab · Novartis Pharmaceuticals Corporation
PRESCRIPTION ONLY (USA)

Beovu ingredients

Active ingredientStrength
Brolucizumab6 mg/.05mL

What Beovu is used for

Beovu is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
Beovu
Generic name
Brolucizumab
Made by
Novartis Pharmaceuticals Corporation
Forms
Injection, Solution
Given
Intravitreal
FDA approval
Biologic licence (BLA) BLA761125
On the US market since
2019

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Beovu?

Beovu (Brolucizumab) is a specialist medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.

What are the ingredients of Beovu?

Beovu contains Brolucizumab (6 mg/.05mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.